Botswana vs Eswatini: HIV/AIDS deaths averted by antiretroviral therapy
Botswana
9,751 deaths
in 2024
Eswatini
10,530 deaths
in 2024
Botswana rank
25th
Eswatini rank
24th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Botswana
- Eswatini
How they compare
Eswatini currently reports 10,530 deaths against 9,751 deaths in Botswana, a difference of 779 deaths.
That makes Eswatini's figure about 1.1 times Botswana's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Eswatini ahead.
Botswana ranks 25th and Eswatini ranks 24th of 157 countries.
Botswana has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Botswana | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.78 deaths | 0 deaths | 14.78 deaths | Botswana |
| 2000s | 7,590 deaths | 2,256 deaths | 5,335 deaths | Botswana |
| 2010s | 14,708 deaths | 9,542 deaths | 5,166 deaths | Botswana |
| 2020s | 10,907 deaths | 10,848 deaths | 58.88 deaths | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Botswana or Eswatini?
- Eswatini, at 10,530 deaths against 9,751 deaths in Botswana as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Botswana and Eswatini?
- 779 deaths, with Eswatini ahead.
- How many years of comparable data are there for Botswana and Eswatini?
- 35 years are reported by both, from 1990 to 2024.
- How do Botswana and Eswatini rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Botswana ranks 25th and Eswatini ranks 24th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.